Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Uzma F. Mehdi, Robert D. Toto(Southwestern Medical Center), Philip Raskin(Tufts University), Beverley Adams‐Huet(Southwestern Medical Center), Gloria Lena Vega(The University of Texas Southwestern Medical Center)
Cited by 386
Related Papers
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
|Circulation|2001|732
Vitamin D Supplementation and Prevention of Type 2 Diabetes
|New England Journal of Medicine|2019|662
Association of urinary pH with body weight in nephrolithiasis
|Kidney International|2004|404
POTASSIUM-MAGNESIUM CITRATE IS AN EFFECTIVE PROPHYLAXIS AGAINST RECURRENT CALCIUM OXALATE NEPHROLITHIASIS
|The Journal of Urology|1997|371